# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002169
Filing Date
2023-11-02
Accepted
2023-11-02 16:06:13
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cldx-20230930x10q.htm iXBRL | 10-Q | 1301969
2 | EX-31.1 | cldx-20230930xex31d1.htm | EX-31.1 | 14901
3 | EX-31.2 | cldx-20230930xex31d2.htm | EX-31.2 | 14945
4 | EX-32.1 | cldx-20230930xex32d1.htm | EX-32.1 | 8729
| Complete submission text file | 0001410578-23-002169.txt |  | 5978718

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | cldx-20230930.xsd | EX-101.SCH | 31363
6 | EX-101.CAL | cldx-20230930_cal.xml | EX-101.CAL | 41304
7 | EX-101.DEF | cldx-20230930_def.xml | EX-101.DEF | 136784
8 | EX-101.LAB | cldx-20230930_lab.xml | EX-101.LAB | 332993
9 | EX-101.PRE | cldx-20230930_pre.xml | EX-101.PRE | 235299
55 | EXTRACTED XBRL INSTANCE DOCUMENT | cldx-20230930x10q_htm.xml | XML | 1254457

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 231372234
SIC: 2835 In Vitro & In Vivo Diagnostic Substances